Very recent studies highlighted a close correlation between MS and serum irisin levels: indeed, lower levels of this adipomyokine were found in the serum of patients with MS, as well as type 2 Diabetes Mellitus. This evidence concerns the gene FNDC5 and myeloid sarcoma.